Duke Clinical Research Institute is announcing a public meeting to disseminate and discuss the results of an NIH-funded project (known as ADAPT) to design a more efficient, less expensive way to conduct a clinical trial to test new antibiotics to treat highly resistant bacterial pathogens. The ADAPT Public Meeting on December 7th will run from 9am-3pm, and will present the study design and facilitate the discussion of the operational and statistical issues associated with running a platform trial capable of simultaneously evaluating multiple antibiotics for treating resistant infections across multiple body sites.
For more information about the meeting, and to register, please use the link here.
For more information about ADAPT, the invited participants, and other related platform trial publications, please see our web page for the Antibiotic Platform Design here.